Incretins- in the care of Type 2 Diabetes Mellitus

Journal Title: Scholars Academic Journal of Biosciences - Year 2016, Vol 4, Issue 4

Abstract

Abstract: The ever increasing incidence of Type2 Diabetes Mellitus (T2DM) in our population calls for a variety of agents to combat this disorder. T2DM is the resultant of Insulin deficiency or the reduced activity of available insulin. Incretins viz. "Glucose dependant Insulinotropic Polypeptide" (GIP) and "Glucagon like Polypeptide-1" (GLP-1) are the intestinal hormones secreted in response to ingestion of food and they increase the secretion of Insulin. Reduced efficacy of these hormones is seen in T2DM. This review analyses the role of Incretins in the therapy of T2DM. A number of studies have been going on to analyse and utilize the beneficial effects of these incretins. Some such studies are reviewed here to give an overall picture of the efficacy of incretins in the care of Type 2 diabetes mellitus. Results and discussion of these studies show that the bioactivity of incretins is short lived as they are easily degraded by the enzyme, Dipeptidyl peptidase 4. A drug that could prevent the incretin degradation and prolong their bioavailability was found to be beneficial. An incretin analogue that could increase the insulin secretion was also studied to be really useful in the treatment of T2DM. In Conclusion Incretin being the initiator of insulin secretion is effective in the care of Type 2 diabetes mellitus as synthetic analogues or as inhibitors of degradative enzyme, dipeptidyl peptidase 4. Keywords: Type2 Diabetes Mellitus, Incretin analogue, Dipeptidyl Peptidase4 inhibitor.

Authors and Affiliations

S. V. Mythili, K. Sumathi, A. Jamunarani

Keywords

Related Articles

Evaluating the role of the appropriate catalysts on the efficacy of biodiesel production from waste cooking oil

Abstract: Concerns over the rapidly depleting sources of energy have led to the need of acquiring alternative sources that are renewable and sustainable. Biodiesel has come under the spotlight as an alternative energy so...

Management of Non Healing Oral Ulcer in Diabetic Patient Using Tropical Application of Epidermal Growth Factor: A Case Report

Abstract: Epidermal growth factor (EGF) is used widely in management of diabetic foot wounds to augment wound healing and to promote epithelialization. There are reports of its use in management of oral mucositis in pati...

Nasal carriage and antimicrobial susceptibility of Staphylococcus aureus, with special reference to methicillin resistance, in health care workers in a tertiary care hospital in south India.

Abstract: Several studies have observed that nasal carriage of MRSA among health care workers, acts as a source of endogenous infection. It also becomes a source for nosocomial and community spread of infections. Nosocom...

Facilitatory Effects of Kinesio Taping on Forearm Extensors in Improving Hand Grip and Pinch Grip Strength

Abstract:Kinesio taping methods are widely used in sports and in rehabilitation as a means to improve muscle strength. The present study aims to determine the immediate and delayed, facilitatory effects of kinesio taping...

Histopathological study of Perimenopausal Abnormal Uterine Bleeding

Abstract: Abnormal Uterine Bleeding (AUB) is defined as any bleeding that does not correspond with the frequency, duration or amount of blood flow of a normal menstrual cycle. Endometrial assessment by endometrial biopsy...

Download PDF file
  • EP ID EP372594
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

S. V. Mythili, K. Sumathi, A. Jamunarani (2016). Incretins- in the care of Type 2 Diabetes Mellitus. Scholars Academic Journal of Biosciences, 4(4), 324-327. https://www.europub.co.uk/articles/-A-372594